Revenio Group Outlines 2027-2029 Strategy Following €290 Million Visionix Acquisition

Revenio Group presented its new strategy and financial targets for 2027–2029 during its Capital Markets Day in Helsinki on September 15, 2026. This event marked the company’s first full presentation since agreeing to acquire French diagnostics group Visionix in April 2026 for €290 million. The announcement details Revenio's strategic direction following this significant acquisition, highlighting how the integration of Visionix will shape the company's operations and goals over the next three years.